Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 25;14(7):e0220371.
doi: 10.1371/journal.pone.0220371. eCollection 2019.

Quantifying the incidence of severe-febrile-illness hospital admissions in sub-Saharan Africa

Affiliations

Quantifying the incidence of severe-febrile-illness hospital admissions in sub-Saharan Africa

Paul Roddy et al. PLoS One. .

Abstract

Severe-febrile-illness (SFI) is a common cause of morbidity and mortality across sub-Saharan Africa (SSA). The burden of SFI in SSA is currently unknown and its estimation is fraught with challenges. This is due to a lack of diagnostic capacity for SFI in SSA, and thus a dearth of baseline data on the underlying etiology of SFI cases and scant SFI-specific causative-agent prevalence data. To highlight the public health significance of SFI in SSA, we developed a Bayesian model to quantify the incidence of SFI hospital admissions in SSA. Our estimates indicate a mean population-weighted SFI-inpatient-admission incidence rate of 18.4 (6.8-31.1, 68% CrI) per 1000 people for the year 2014, across all ages within areas of SSA with stable Plasmodium falciparum transmission. We further estimated a total of 16,200,337 (5,993,249-27,321,779, 68% CrI) SFI hospital admissions. This analysis reveals the significant burden of SFI in hospitals in SSA, but also highlights the paucity of pathogen-specific prevalence and incidence data for SFI in SSA. Future improvements in pathogen-specific diagnostics for causative agents of SFI will increase the abundance of SFI-specific prevalence and incidence data, aid future estimations of SFI burden, and enable clinicians to identify SFI-specific pathogens, administer appropriate treatment and management, and facilitate appropriate antibiotic use.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Final fitted relationship between incidence of IPD admissions for severe-febrile-illness (all ages) and estimated prevalence of community-acquired febrile illness (<5 years of age).
The median of the final fitted relationship is represented by the black line, with 68% and 95% credible intervals overlain in increasingly light grey. The overlain points are the observations of the 45 country-years of the incidence of severe-febrile-illness (all ages) versus the national estimated prevalence of community-acquired fever (<5 years of age).
Fig 2
Fig 2. Incidence rate (per 1000 people) of SFI-IPD admissions for severe-febrile-illness in 2014 for each sub-Saharan African country within areas of stable P. falciparum malaria transmission.
Fig 3
Fig 3. Incidence rate (per 1000 people) of 2014 IPD admissions for severe-febrile-illness due to all illnesses other than severe malaria (but including admissions for uncomplicated malaria) for each sub-Saharan African country within areas of stable P. falciparum transmission.
Estimates for severe malaria IPD admissions were unavailable for Equatorial Guinea, South Africa, South Sudan, and eSwatini, thus these countries were not included in this section of the analysis.
Fig 4
Fig 4. Incidence rate (per 1000 people) of 2014 IPD admissions for severe malaria (not including uncomplicated malaria) for each sub-Saharan African country within areas of stable P. falciparum malaria transmission.
These estimates were produced by Camponovo et al. [46]. Estimates for severe malaria IPD admissions were unavailable for Equatorial Guinea, South Africa, South Sudan, and eSwatini, thus these countries were not included in this section of the analysis.
Fig 5
Fig 5. The proportion of 2014 IPD admissions for severe-febrile-illness that were causally due to illnesses other than severe malaria for each sub-Saharan African country within areas of stable P. falciparum transmission.
Illnesses other than severe malaria include admissions for uncomplicated malaria. Estimates for severe malaria IPD admissions were unavailable for Equatorial Guinea, South Africa, South Sudan, and eSwatini, thus these countries were not included in this section of the analysis.

References

    1. Maze MJ, Bassat Q, Feasey NA, Mandomando I, Musicha P, Crump JA. The epidemiology of febrile illness in sub-Saharan Africa: implications for diagnosis and management. Clinical Microbiology and Infection. Volume 24, Issue 8, August 2018, Pages 808–814. 10.1016/j.cmi.2018.02.011. - DOI - PMC - PubMed
    1. Crump JA, Kirk MD (2015). Estimating the Burden of Febrile Illness. PLoS Neglected Tropical Diseases. 9(12): e0004040 10.1371/journal.pntd.0004040 - DOI - PMC - PubMed
    1. Prasad N, Sharples KJ, Murdoch DR, Crump JA. Community Prevalence of Fever and Relationship with Malaria among Infants and Children in Low-Resource Areas. The American Journal of Tropical Medicine and Hygiene. 2015. 93(1), pp. 178–180. 10.4269/ajtmh.14-0646 - DOI - PMC - PubMed
    1. Feikin DR, Scott JA, Gessner BD. Use of vaccines as probes to define disease burden. The Lancet. 2014;383:1762–70. . - PMC - PubMed
    1. Biritwum RB, Welbeck J, Barnish G. Incidence and management of malaria in two communities of different socio-economic level, in Accra, Ghana. Annals of Tropical Medicine & Parasitology. 2000;94(8):771–8. - PubMed

MeSH terms